These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9131823)
1. A note on the relationship between lifetime tumor risk and expected time to tumor. Gaylor DW; Zheng Q Risk Anal; 1997 Feb; 17(1):5-7. PubMed ID: 9131823 [No Abstract] [Full Text] [Related]
2. Cellular epigenetics and the origin of cancer. Cuthill S Bioessays; 1994 Jun; 16(6):393-4. PubMed ID: 8080428 [No Abstract] [Full Text] [Related]
3. Mechanisms of carcinogenesis and biologically based models for estimation and prediction of risk. Moolgavkar S; Krewski D; Schwarz M IARC Sci Publ; 1999; (131):179-237. PubMed ID: 10505297 [No Abstract] [Full Text] [Related]
4. Carcinogenesis modeling: from molecular biology to epidemiology. Moolgavkar SH Annu Rev Public Health; 1986; 7():151-69. PubMed ID: 3521642 [No Abstract] [Full Text] [Related]
5. Recent developments toward a unifying concept of carcinogenesis. Scarpelli DG Ann Clin Lab Sci; 1983; 13(3):249-59. PubMed ID: 6347024 [TBL] [Abstract][Full Text] [Related]
6. [The risk assessment of cancer morbidity in the joint action of carcinogens]. Shaĭkina OI; Shaĭkin AB; Kon'shina LG Gig Sanit; 1999; (1):41-3. PubMed ID: 10199078 [No Abstract] [Full Text] [Related]
7. Latency periods in neoplastic diseases. Polednak AP Am J Epidemiol; 1974 Nov; 100(5):354-6. PubMed ID: 4422307 [No Abstract] [Full Text] [Related]
8. Biological models of carcinogenesis and quantitative cancer risk assessment. Moolgavkar SH Risk Anal; 1994 Dec; 14(6):879-82. PubMed ID: 7846320 [TBL] [Abstract][Full Text] [Related]
9. Causes and risk factors for childhood cancer. Pisani P; Parodi S; Magnani C Epidemiol Prev; 2013; 37(1 Suppl 1):234-54. PubMed ID: 23585447 [No Abstract] [Full Text] [Related]
10. Sixth Aspen Cancer Conference: molecular mechanisms of genetic deregulation in toxicity and carcinogenesis. Tennant RW; Harris CC; Kaufman DG; Nesnow S; Slaga TJ; Stevenson DE; Trump BF Mol Carcinog; 1993; 7(2):67-72. PubMed ID: 8096139 [No Abstract] [Full Text] [Related]
11. A dose-response model for estimating lifetime tumor risks when cell killing occurs. Scott BR Bull Math Biol; 1981; 43(4):487-501. PubMed ID: 7317675 [No Abstract] [Full Text] [Related]
12. The 'cancell' theory of carcinogenesis: re-evolution of an ancient, holistic neoplastic unicellular concept of cancer. Grossgebauer K Med Hypotheses; 1995 Dec; 45(6):545-55. PubMed ID: 8771049 [TBL] [Abstract][Full Text] [Related]
13. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer. Pitot HC; Goldsworthy T; Moran S J Supramol Struct Cell Biochem; 1981; 17(2):133-46. PubMed ID: 7033553 [No Abstract] [Full Text] [Related]
14. The time to tumor approach in risk assessment. Albert RE Basic Life Sci; 1986; 38():551-6. PubMed ID: 3741347 [TBL] [Abstract][Full Text] [Related]
15. Sonocarcinogenesis: loud noise may cause malignant transformation of cells. Ghabili K; Shoja MM; Tubbs RS; Rahimi-Ardabili B; Ansarin K Med Hypotheses; 2007; 69(5):1156-7. PubMed ID: 17445996 [No Abstract] [Full Text] [Related]
16. NATO Advanced research workshop: Endocrine disrupters and carcinogenic risk assessment. May 8-12, 2001, Bialystok, Poland. Abstracts. Folia Histochem Cytobiol; 2001; 39 Suppl 1():7-87. PubMed ID: 11534551 [No Abstract] [Full Text] [Related]